Impact of gut hormone FGF-19 on type-2 diabetes and mitochondrial recovery in a prospective study of obese diabetic women undergoing bariatric surgery

Table 2 Comparisons of surgery-induced changes in serum FGF-19 levels between biliopancreatic diversion (BPD), laparoscopic greater curvature plication (LGCP) and laparoscopic adjustable gastric banding (LAGB) bariatric procedures

Bariatric surgery (n)	Percent of patients with increase (%)	Change from pre- to post-surgery (%)^a
Bariatric surgery (n)	Percent of patients with increase (%)	Mean (SD)	Median (IQR)
BPD (12)	58.3	158.90 (180.60)	121.72 (52.73–152.67)
LGCP (15)	73.3	181.32 (209.65)	135.41 (74.75–172.57)
LAGB (12)	16.7	84.27 (88.49)*	63.28 (41.66–79.24)*

Table shows percentage of patients (%) who exhibited increased serum FGF-19 post-surgery relative to pre-surgery levels. The Wilcoxon signed-rank test was used for within group comparisons of pre- and post-surgery levels (*P < 0.05)
^aThe Kruskal–Wallis H test determined there were significant differences in serum FGF-19 between the three surgery types (χ² = 7.655; P = 0.022)
SD standard deviation, IQR interquartile range

ISSN: 1741-7015